By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Fibrocell Science, Inc. 

405 Eagleview Boulevard

Exton  Pennsylvania  19341  U.S.A.
Phone: 484-713-6000 Fax: 484-713-6001


SEARCH JOBS


Industry
Biotechnology






Company News
Fibrocell (FCSC) Completes Enrollment In NC1+ Cohort Of Phase I/II Clinical Trial Of FCX-007 For Treatment Of Recessive Dystrophic Epidermolysis Bullosa 9/19/2016 7:53:14 AM
Fibrocell (FCSC) Announces Closing Of $18 Million Private Placement 9/8/2016 7:40:04 AM
Fibrocell (FCSC) Announces Convertible Debt And Warrant Financing Of Up To $25 Million 8/9/2016 8:25:14 AM
Fibrocell (FCSC) Announces Proposed Public Offering Of Common Stock And Warrants 8/9/2016 8:21:55 AM
Fibrocell (FCSC) Reports Second Quarter 2016 Financial Results And Recent Operational Highlights 8/4/2016 8:14:47 AM
Fibrocell (FCSC) To Host Conference Call And Webcast On Thursday, August 4, 2016 To Discuss Second Quarter 2016 Financial Results And Recent Operational Highlights 7/28/2016 8:06:18 AM
Fibrocell (FCSC) Announces First Subjects Enrolled In Phase I/II Clinical Trial Of FCX-007 For Treatment Of Recessive Dystrophic Epidermolysis Bullosa 7/28/2016 8:01:42 AM
Fibrocell (FCSC) To Present At Cantor Fitzgerald’s 2nd Annual Healthcare Conference 7/8/2016 9:48:46 AM
Fibrocell (FCSC) Looking for Azficel-T Buyer and Lays Off Employees as Program Winds Down 6/30/2016 7:21:17 AM
Fibrocell (FCSC) Announces Initiation Of Patient Recruitment In Phase I/II Clinical Trial Of FCX-007 For Treatment Of Recessive Dystrophic Epidermolysis Bullosa 6/13/2016 8:05:33 AM
12345678910...
//-->